Literature DB >> 11041054

Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.

R Montironi1, R Mazzucchelli, F Algaba, A Lopez-Beltran.   

Abstract

High grade prostatic intraepithelial neoplasia (PIN) is the most likely precursor of prostatic carcinoma. PIN has a high predictive value as a marker for carcinoma, and its identification in biopsy specimens warrants repeat biopsy for concurrent or subsequent carcinoma. The only methods of detection are biopsy and transurethral resection; PIN does not greatly raise the concentration of serum prostate specific antigen (PSA) or its derivatives, does not induce a palpable mass, and cannot be detected by ultrasound. Androgen deprivation decreases the prevalence and extent of PIN, suggesting that this form of treatment might play a role in chemoprevention. Radiotherapy is also associated with a decreased incidence of PIN.

Entities:  

Mesh:

Year:  2000        PMID: 11041054      PMCID: PMC1731241          DOI: 10.1136/jcp.53.9.655

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  91 in total

Review 1.  Minimal criteria for the diagnosis of prostate cancer on needle biopsy.

Authors:  D G Bostwick; K A Iczkowski
Journal:  Ann Diagn Pathol       Date:  1997-12       Impact factor: 2.090

Review 2.  Pathological changes in prostate lesions after androgen manipulation.

Authors:  R Montironi; C C Schulman
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

3.  Working standards in prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.

Authors:  F Algaba; J I Epstein; G Fabus; B Helpap; R B Nagle; M Polito
Journal:  Pathol Res Pract       Date:  1995-09       Impact factor: 3.250

Review 4.  Significance of duct-acinar dysplasia in prostatic carcinogenesis.

Authors:  J E McNeal
Journal:  Prostate       Date:  1988       Impact factor: 4.104

5.  Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimens.

Authors:  P B Gaudin; I A Sesterhenn; K J Wojno; F K Mostofi; J I Epstein
Journal:  Urology       Date:  1997-04       Impact factor: 2.649

6.  Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining.

Authors:  J E McNeal; O Haillot; C Yemoto
Journal:  Prostate       Date:  1995-11       Impact factor: 4.104

7.  Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.

Authors:  J M Cunningham; A Shan; M J Wick; S K McDonnell; D J Schaid; D J Tester; J Qian; S Takahashi; R B Jenkins; D G Bostwick; S N Thibodeau
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

8.  Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?

Authors:  G Raviv; A R Zlotta; T h Janssen; F Descamps; J P Vanegas; A Verhest; C C Schulman
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

9.  Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications.

Authors:  M A Rubin; A de La Taille; E Bagiella; C A Olsson; K M O'Toole
Journal:  Am J Surg Pathol       Date:  1998-07       Impact factor: 6.394

10.  Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma.

Authors:  O A Armas; A G Aprikian; J Melamed; C Cordon-Cardo; D W Cohen; R Erlandson; W R Fair; V E Reuter
Journal:  Am J Surg Pathol       Date:  1994-10       Impact factor: 6.394

View more
  13 in total

1.  Electronic publishing and internet learning.

Authors:  P J van Diest; H Holzel; M Reid; M Crook; G Spickett
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  High grade prostatic intraepithelial neoplasia with squamous differentiation.

Authors:  M Melissari; A Lopez Beltran; R Mazzucchelli; E Froio; D G Bostwick; R Montironi
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

3.  Quantitative immunohistochemical detection of the molecular expression patterns in proliferative inflammatory atrophy.

Authors:  M Karaivanov; K Todorova; A Kuzmanov; S Hayrabedyan
Journal:  J Mol Histol       Date:  2006-12-15       Impact factor: 2.611

4.  Chemopreventive trials in urologic cancer.

Authors:  Vahagn R Ashughyan; Sibylle Marihart; Bob Djavan
Journal:  Rev Urol       Date:  2006

Review 5.  My approach to intraductal lesions of the prostate gland.

Authors:  M Pickup; T H Van der Kwast
Journal:  J Clin Pathol       Date:  2007-01-19       Impact factor: 3.411

6.  Prostatic intraepithelial neoplasia in genetically engineered mice.

Authors:  Jae-Hak Park; Judy E Walls; Jose J Galvez; Minjung Kim; Cory Abate-Shen; Michael M Shen; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.

Authors:  Pieter J L De Visschere; Anne Vral; Gianpaolo Perletti; Eva Pattyn; Marleen Praet; Vittorio Magri; Geert M Villeirs
Journal:  Eur Radiol       Date:  2016-08-04       Impact factor: 5.315

8.  Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: a biopsy study in chronic prostatitis patients.

Authors:  A Vral; V Magri; E Montanari; G Gazzano; V Gourvas; E Marras; G Perletti
Journal:  Int J Oncol       Date:  2012-10-01       Impact factor: 5.650

9.  Strategies for prostate cancer prevention: Review of the literature.

Authors:  H Krishna Moorthy; P Venugopal
Journal:  Indian J Urol       Date:  2008-07

10.  The frequency of latent prostate carcinoma in autopsies of over 50 years old males, the Iranian experience.

Authors:  Ali Zare-Mirzaie; Payam Balvayeh; Mohammad Ali Imamhadi; Maryam Lotfi
Journal:  Med J Islam Repub Iran       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.